[
  {
    "ts": null,
    "headline": "Pre-Tariff Pharma Stockpiling Gives Irish Economy a Huge Booster Shot",
    "summary": "Ireland’s economy grew three times as rapidly as first estimated in the first quarter. That was driven by stockpiling of pharmaceuticals and other goods by U.S. businesses ahead of threatened tariffs.",
    "url": "https://finnhub.io/api/news?id=6a764a9c55cd08349eb562c42db48bdd99c0df18c9c9bc39199764d0399cba34",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749129059,
      "headline": "Pre-Tariff Pharma Stockpiling Gives Irish Economy a Huge Booster Shot",
      "id": 135063711,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Ireland’s economy grew three times as rapidly as first estimated in the first quarter. That was driven by stockpiling of pharmaceuticals and other goods by U.S. businesses ahead of threatened tariffs.",
      "url": "https://finnhub.io/api/news?id=6a764a9c55cd08349eb562c42db48bdd99c0df18c9c9bc39199764d0399cba34"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly: If You Don't Buy On Weight Loss Promise Now, You Probably Never Will",
    "summary": "Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and the risks. Click for my LLY stock update.",
    "url": "https://finnhub.io/api/news?id=37b780f30773b21e974178afc86b2f15623dfb8f492d83a54bcd08e7e9c504a9",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749128946,
      "headline": "Eli Lilly: If You Don't Buy On Weight Loss Promise Now, You Probably Never Will",
      "id": 135056101,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1300813763/image_1300813763.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and the risks. Click for my LLY stock update.",
      "url": "https://finnhub.io/api/news?id=37b780f30773b21e974178afc86b2f15623dfb8f492d83a54bcd08e7e9c504a9"
    }
  },
  {
    "ts": null,
    "headline": "REGN Strengthens Obesity Pipeline: Will the Move Revive the Stock?",
    "summary": "REGN inks a $2B-plus obesity drug deal with Hansoh, aiming to expand its pipeline amid slumping Eylea sales and pipeline setbacks.",
    "url": "https://finnhub.io/api/news?id=8ef4c847711b812db76cef7bb42143d35b90bf8308ea057dbb0a07d6878d43a6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749127500,
      "headline": "REGN Strengthens Obesity Pipeline: Will the Move Revive the Stock?",
      "id": 135046541,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "REGN inks a $2B-plus obesity drug deal with Hansoh, aiming to expand its pipeline amid slumping Eylea sales and pipeline setbacks.",
      "url": "https://finnhub.io/api/news?id=8ef4c847711b812db76cef7bb42143d35b90bf8308ea057dbb0a07d6878d43a6"
    }
  },
  {
    "ts": null,
    "headline": "Should You Invest $1,000 in Eli Lilly today?",
    "summary": "Eli Lilly is a pharma player, but it offers the growth of a tech stock thanks to its weight loss drugs portfolio.  The weight loss market could represent a multibillion-dollar opportunity well into the next decade.  Eli Lilly (NYSE: LLY) sells a broad range of medicines, from cancer and immunology drugs to treatments for migraine.",
    "url": "https://finnhub.io/api/news?id=c1f210085cf01cbf595f4d2761b42b89283d33514316960e6b05154b7c446934",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749111300,
      "headline": "Should You Invest $1,000 in Eli Lilly today?",
      "id": 135043488,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly is a pharma player, but it offers the growth of a tech stock thanks to its weight loss drugs portfolio.  The weight loss market could represent a multibillion-dollar opportunity well into the next decade.  Eli Lilly (NYSE: LLY) sells a broad range of medicines, from cancer and immunology drugs to treatments for migraine.",
      "url": "https://finnhub.io/api/news?id=c1f210085cf01cbf595f4d2761b42b89283d33514316960e6b05154b7c446934"
    }
  },
  {
    "ts": null,
    "headline": "Apotex Not Entitled To Damages For Delayed Generic Drug Launch",
    "summary": "The Ontario Court of Appeal's recent decision in Apotex Inc. v. Eli Lilly and Company offers important clarity for pharmaceutical companies engaged in patent litigation under the Patented Medicines ...",
    "url": "https://finnhub.io/api/news?id=d5f7826e87b02f791a7acf9e133ad55d0c302cca11ee2c7edae857946b097ec3",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749111191,
      "headline": "Apotex Not Entitled To Damages For Delayed Generic Drug Launch",
      "id": 135045175,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "The Ontario Court of Appeal's recent decision in Apotex Inc. v. Eli Lilly and Company offers important clarity for pharmaceutical companies engaged in patent litigation under the Patented Medicines ...",
      "url": "https://finnhub.io/api/news?id=d5f7826e87b02f791a7acf9e133ad55d0c302cca11ee2c7edae857946b097ec3"
    }
  },
  {
    "ts": null,
    "headline": "China's Biotech Revolution Rolls Forward To The Global Frontiers Of Medical Therapeutics",
    "summary": "In the past five years, China has leaped from fast follower to global pioneer in drug discovery and development. Click to read.",
    "url": "https://finnhub.io/api/news?id=3c697230053421deb8e8262c7e1872c8494cfb3d07ebb42a163e485414df703f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749111000,
      "headline": "China's Biotech Revolution Rolls Forward To The Global Frontiers Of Medical Therapeutics",
      "id": 135045218,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1389605524/image_1389605524.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "In the past five years, China has leaped from fast follower to global pioneer in drug discovery and development. Click to read.",
      "url": "https://finnhub.io/api/news?id=3c697230053421deb8e8262c7e1872c8494cfb3d07ebb42a163e485414df703f"
    }
  }
]